| 1 | Zeng G, Mai, Z, Xia, S, et al. Prevalence of kidney stones in China: an ultrasonography based cross-sectional study [J]. Bju Int, 2017, 120(1): 109-116. | 
																													
																							| 2 | Mai Z, Li X, Cui Z, et al. Reference intervals for stone risk factors in 24-h urine among healthy adults of the Han population in China [J]. Clin Chem Lab Med, 2018, 56(4): 642-648. | 
																													
																							| 3 | Ciftcioglu N, Mikael Björklund, Kuorikoski K, et al. Nanobacteria: An infectious cause for kidney stone formation [J]. Kidney International, 1999, 56(5): 1893-1898. | 
																													
																							| 4 | 任海林,颜东文,史葆光, 等. 上尿路结石中纳米细菌的检测 [J]. 中华泌尿外科杂志, 2006, 27(9): 620. | 
																													
																							| 5 | 蔡宇雨,邹良强,刘娜. 不同条件保存24小时尿液对生化检测的影响 [J]. 标记免疫分析与临床, 2019, 26(5): 837-840. | 
																													
																							| 6 | 李丽丽,陈振玲,刘铁兵, 等. 尿样保存温度和时间对尿中钙、镁检测的影响 [J]. 中国职业医学, 2019, 46(2): 221-224. | 
																													
																							| 7 | 叶涛,叶章群. 炎症和氧化应激反应与肾结石形成的研究进展 [J]. 中华泌尿外科杂志, 2018, 39(9): 711. | 
																													
																							| 8 | 邓耀良,刘云龙,陶芝伟, 等. 细胞-晶体反应介导的炎症在肾内草酸钙晶体形成中的作用[J]. 中华外科杂志, 2018, 56(10): 733-736. | 
																													
																							| 9 | 朱敏,曾锋,崔雨, 等. 基质Gla蛋白与骨形成蛋白2在草酸钙肾结石患者Randall钙斑中的表达 [J]. 中南大学学报(医学版), 2017, 42(3): 277-283. | 
																													
																							| 10 | Dhayat NA, Gradwell MW, Pathare G, et al. Furosemide / fludrocortisone test and clinical parameters to diagnose incomplete distal renal tubular acidosis in kidney stone formers [J]. Clin J Am Soc Nephro, 2017, 12(9): 1507-1517. | 
																													
																							| 11 | Alelign T, Petros B. Kidney stone disease: an update on current concepts [J]. Adv Urol, 2018, 2018: 3068365. | 
																													
																							| 12 | Kajander EO, Ciftcioglu N. Nanobacteria: an alternative mechanism for pathogenic intra- and extracellular calcification and stone formation [J]. Proc Natl Acad Sci USA, 1998, 95(14): 8274-8279. | 
																													
																							| 13 | Hjelle JT, Miller-Hjelle MA, Poxton IR, et al. Endotoxin and nanobacteria in polycystic kidney disease [J]. Kidney Int, 2000, 57(6): 2360-2374. | 
																													
																							| 14 | 郝志强,王勤章,倪钊, 等. Mirco-CT对纳米细菌大鼠肾结石的动态观测 [J]. 实用医药杂志, 2018, 35(4): 336-339. | 
																													
																							| 15 | Silay MS, Miroglu C. The risk of urolithiasis recurrence may be reduced with anti-nanobacterial therapy [J]. Med Hypotheses, 2007, 68(6): 1348-1350. | 
																													
																							| 16 | 申茂磊,王勤章,郑丽英, 等. 四环素抗纳米细菌治疗对泌尿系结石患者HK-2细胞损伤及结晶滞留的影响 [J]. 实用医药杂志, 2018, 35(9): 780-783. | 
																													
																							| 17 | Ezzeldeen NA, Emam M. Molecular identification and detection of nanobacteria [J]. Nano Science & Nano Technology: An Indian Journal, 2016. | 
																													
																							| 18 | 张彬,张高岳,颜俊峰, 等. 特发性草酸钙结石患者24h尿成石危险因素的分析 [J]. 浙江临床医学, 2016, 18(8): 1381-1383. | 
																													
																							| 19 | 蔡景兰. 24h尿液成石危险因素测定尿液标本保存的研究 [J]. 国际检验医学杂志, 2013, 34(17): 2335-2336. | 
																													
																							| 20 | 胡卫国,李建兴,叶章群. 2019年欧洲泌尿外科学会年会泌尿系结石诊治热点和进展 [J].中华泌尿外科杂志, 2019, 40(4): 251-252. | 
																													
																							| 21 | Dion M, Ankawi G, Chew B, et al. CUA guideline on the evaluation and medical management of the kidney stone patient - 2016 update [J]. Can Urol Assoc J, 2016, 10(11-12): 347-358. |